|
Thursday, October 23, 2008 |
|
|
16:30-19:00 |
Opening Plenary Session |
|
| 19:00 |
Welcome Reception |
|
|
|
|
|
|
|
Friday, October 24, 2008 |
|
|
Hall A |
Hall B |
Hall C |
|
|
Multiple Sclerosis (MS) |
Stroke |
Parkinson's Disease (PD) / Pain |
|
08:30-10:00 |
Session 1
MS / Clinical Aspects
Sponsored by an unrestricted grant from Merck Serono |
Session 5
Stroke Prevention 1 |
Session 9
Treatment of PD 1 |
|
10:00-10:30 |
Coffee Break |
|
10:30-12:00 |
Session 2
Etiology of MS: Environmental vs. Genetic Factors |
Session 6
Acute Ischemic Stroke |
Session 10
Treatment of PD 2 |
|
12:00-13:30 |
Session 3
MS Therapy 1
Sponsored by an unrestricted grant from Teva Sanofi-Aventis |
Session 7
Stroke Prevention 2 |
Session 11
Headache 1
Sponsored by MSD
Biomarkers for Migraine |
|
13:30-14:30 |
Lunch Break
Sponsored by Boehringer Ingelheim |
|
14:30-16:30 |
Satellite Symposium
Challenges in PD Treatment
Sponsored by Boehringer Ingelheim |
|
16:30-17:00 |
Coffee Break |
|
17:00-18:15 |
Session 4
MS Therapy 2 |
Session 8
Stroke and Dementia Prevention |
Session 12
Headache 2 |
|
Free Communications: Stroke |
|
|
|
|
Saturday, October 25, 2008 |
|
|
Hall A |
Hall B |
Hall C |
|
|
Epilepsy |
|
Neuropsychiatry |
|
08:30-10:00 |
Session 13
Progression of Epilepsy |
Session 17
Update on Novel Treatments in MS |
Session 20
ALS/Oxidative Stress |
|
|
|
10:00-10:30 |
Coffee Break |
|
10:30-12:00 |
Session 14
Epilepsy Treatments 1 |
Update on Novel Treatments in MS continued |
Satellite Symposium
Healthy Brain Aging
Sponsored by
Ana Aslan International Academy of Anti-Aging |
|
Session 18
Biomarkers for MS |
|
12:00-13:30 |
Satellite Symposium
Betaferon: 5 Years Benefit of Early Treatment
Sponsored by Bayer Healthcare |
|
13:30-14:30 |
Lunch Break
Sponsored in part by Ana Aslan International Academy of Anti-Aging |
|
14:30-16:30 |
Session 15
Epilepsy Treatments 2 |
Satellite Symposium
Neuroprotection and Neuroplasticity
Sponsored by Society for the Study of Neuroprotection and Neuroplasticity |
Session 21
Autoimmune Diseases
Sponsored by an unrestricted grant from Talecris Biotherapeutics |
|
Psychogenic Seizures |
|
16:30-17:00 |
Coffee Break |
|
17:00-19:00 |
Session 16
Epilepsy Round table Case discussion |
Session 19
Dementia |
Session 22
Rehabilitation
Sponsored in part by an unrestricted grant from Eisai Europe Ltd. and Solstice Neurosciences |
|
Free communications: Dementia |
|
|
|
|
|
Sunday, October 26, 2008 |
|
|
|
Hall A |
Hall B |
|
|
|
Dementia |
|
|
|
08:30-10:00 |
Session 23
Pathogenesis and Therapy of Dementia |
Session 26
Pain and Fatique |
|
|
10:00-10:30 |
Coffee Break |
|
|
10:30-13:20 |
Session 24
Biomarkers of Alzheimer's Disease |
Session 27
Free Communications: Pain |
|
|
Session 25
Therapy
|
Session 28
PD: New Players on the Block |
|
|
Free Communications: Various Topics
Best Absract Award will be presented |
|
WebStudio.co.il